Black Afghani 1:1

Cannabis Strain by Seattle Chronic Seeds

Introduction
A 1:1 THC:CBD ratio changes the character of any strain fundamentally — shifting from purely recreational/psychoactive territory into the cannabinoid-balanced space that has attracted significant interest for therapeutic applications. Seattle Chronic Seeds' Black Afghani 1:1 combines the dark-indica Afghan heritage with a cannabinoid profile designed for something other than maximum intoxication.

Lineage
**Genetic Lineage** Black Afghani 1:1 is an indica/sativa hybrid from Seattle Chronic Seeds, available as regular seeds with no published flowering time. The "1:1" designation indicates a roughly equal ratio of THC to CBD — a balanced cannabinoid profile typically produced by crossing a high-THC variety with a high-CBD variety, or through selection of naturally balanced phenotypes. The Black Afghani foundation suggests dark-phenotype Afghan genetics; the CBD component's origin is undisclosed. Seattle Chronic Seeds is a Washington State-based operation distributing through Instagram. Limited grower reports available.

Terpenes
**Terpene Profile** Afghani genetics typically express earthy, hashish-forward terpene profiles: myrcene-dominant with sweet wood, mild spice, and occasional fruit undertones. The CBD-contributing parent's terpene character is unknown. No formal terpene analysis published.

Growth
**Growth Characteristics** No flowering time, height, or yield data has been published. Regular seeds. The Afghani indica heritage suggests compact, bushy structure with shorter internodes.

Effects
**Reported Effects & Experience** The 1:1 THC:CBD ratio produces a notably different experience than high-THC indicas: the CBD modulates the psychoactive intensity, producing a calmer, more functional effect with less cognitive impairment. The Afghani heritage still provides physical relaxation as a baseline.

Documentation
**Medical Applications** The balanced 1:1 cannabinoid profile is of particular interest for pain, anxiety, and inflammation management, where CBD's anxiolytic and anti-inflammatory properties complement THC's analgesic effects. No clinical data specific to this strain.

⚠️ This information is for educational purposes only and should not be considered medical advice.

Sources: https://www.instagram.com/seattlechronicseeds/